• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
73,610.81 86.55
( 0.12%)
Global Indices
Nasdaq
50,812.84 -74.94
(-0.15%)
Dow Jones
7,426.81 22.07
(0.30%)
Hang Seng
63,697.20 -2,890.92
(-4.34%)
Nikkei 225
10,368.25 0.20
(0.00%)
Forex
USD-INR
95.22 -0.51
(-0.53%)
EUR-INR
109.67 -1.54
(-1.39%)
GBP-INR
126.98 -1.60
(-1.25%)
JPY-INR
0.59 0.00
(-0.77%)

EQUITY - MARKET SCREENER

IRB InvIT Fund
Industry :  Construction
BSE Code
ISIN Demat
Book Value()
540526
INE183W23014
105.4574955
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
IRBINVIT
6.81
4797.1
EPS(TTM)
Face Value()
Div & Yield %
8.91
102
9.43
 

u r energy (india) ltd
Bacil Pharma reports standalone net profit of Rs 0.04 crore in the December 2025 quarter
Feb 13,2026
Net profit of Bacil Pharma reported to Rs 0.04 crore in the quarter ended December 2025 as against net loss of Rs 0.06 crore during the previous quarter ended December 2024. There were no Sales reported in the quarter ended December 2025 and during the previous quarter ended December 2024.